Published in Infect Agent Cancer on January 20, 2014
Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival. J Virol (2015) 0.77
Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer. Infect Agent Cancer (2014) 0.77
Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7. J Biol Chem (2016) 0.76
Salivary and serum IL-10, TNF-α, TGF-β, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infections. Infect Agent Cancer (2016) 0.76
Fulminant anaplastic large cell lymphoma (ALCL) concomitant with primary cytomegalovirus (CMV) infection, and human herpes virus 8 (HHV-8) infection together with Epstein-Barr-virus (EBV) reactivation in a patient with asymptomatic HIV-infection. Infect Agent Cancer (2016) 0.75
Mortality in cancer patients previously diagnosed with herpes zoster in the hospital setting: a nationwide cohort study. Br J Cancer (2015) 0.75
BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha. J Virol (2016) 0.75
Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol (2007) 8.31
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
A viral inhibitor of peptide transporters for antigen presentation. Nature (1995) 4.26
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol (2007) 2.99
Epstein-Barr virus and cancer. Clin Cancer Res (2004) 2.78
Cancer epidemiology in the last century and the next decade. Nature (2001) 2.72
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev (2011) 2.22
Aging, immunity, and the varicella-zoster virus. N Engl J Med (2005) 2.20
Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol (2004) 2.20
Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol (2012) 2.02
Next generation of immunotherapy for melanoma. J Clin Oncol (2008) 1.69
EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist (2008) 1.61
The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia (2009) 1.49
Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol (2003) 1.45
Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol (2004) 1.36
Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J Virol (1998) 1.35
Kaposi's sarcoma-associated herpesvirus immune modulation: an overview. J Gen Virol (2006) 1.34
KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol (1999) 1.30
Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management. Am J Med (1988) 1.23
Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products. Semin Cancer Biol (2008) 1.20
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus. Trends Microbiol (2009) 1.20
Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis. Semin Cancer Biol (2008) 1.13
Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma? Exp Hematol (2006) 1.12
Recent topics related to human herpesvirus 6 cell tropism. Cell Microbiol (2009) 1.12
The KGD motif of Epstein-Barr virus gH/gL is bifunctional, orchestrating infection of B cells and epithelial cells. MBio (2012) 1.12
Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. J Immunol (1992) 1.09
Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv Virus Res (2010) 1.09
Epstein-Barr virus is associated with gastric carcinoma: the question is what is the significance? World J Gastroenterol (2008) 1.04
Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J Virol (1999) 1.04
Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J Virol (2009) 1.04
Human herpesvirus 6 in hematological malignancies. J Clin Exp Hematop (2009) 1.03
Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus. Eur J Immunol (1991) 1.00
Herpes simplex virus remodels T-cell receptor signaling, resulting in p38-dependent selective synthesis of interleukin-10. J Virol (2007) 0.99
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders. Haematologica (2010) 0.98
Role of infectious agents in the carcinogenesis of brain and head and neck cancers. Infect Agent Cancer (2013) 0.97
Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies. Front Microbiol (2012) 0.97
Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus. Viral Immunol (2002) 0.96
Case report: occupationally related recurrent varicella (chickenpox) in a hospital nurse. Environ Health Perspect (2005) 0.95
Human herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their immunostimulatory activity. Immunol Lett (2007) 0.95
Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma. J Clin Invest (1999) 0.94
Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation. Viruses (2012) 0.94
Herpes simplex inhibits the capacity of lymphoblastoid B cell lines to stimulate CD4+ T cells. J Immunol (2001) 0.94
Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma. PLoS Pathog (2012) 0.93
Immune regulation of human herpesviruses and its implications for human transplantation. Am J Transplant (2013) 0.92
Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection. Med Microbiol Immunol (2012) 0.91
The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system. J Biol Chem (2004) 0.89
Prognostic role of Ebstein-Barr virus latent membrane protein-1 and interleukin-10 expression in patients with nasopharyngeal carcinoma. Cancer Invest (2004) 0.89
EBV associated lymphomas in 2008 WHO classification. Pathol Res Pract (2013) 0.88
The herpes simplex virus type 2 gene ICP10PK protects from apoptosis caused by nerve growth factor deprivation through inhibition of caspase-3 activation and XIAP up-regulation. J Neurochem (2007) 0.88
Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells. Virology (2009) 0.87
Inhibition of apoptosis by primary isolates of herpes simplex virus. Arch Virol (2001) 0.86
Presence of human herpes virus 6 (HHV6) in pediatric lymphomas: impact on clinical course and association with cytomegalovirus infection. Virol J (2010) 0.86
Chromosomally-integrated human herpesvirus 6 in familial glioma etiology. Med Hypotheses (2012) 0.84
Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology. Virulence (2012) 0.84
Human herpesvirus 6 latent infection in patients with glioma. J Infect Dis (2012) 0.84
Human herpes simplex viruses in benign and malignant thyroid tumours. J Pathol (2010) 0.83
The cause of invasive cervical cancer could be multifactorial. Biomed Pharmacother (2000) 0.83
Human herpesvirus type 6 and type 1 infection increases susceptibility to nonmelanoma skin tumors. Cancer Lett (2004) 0.82
Quantitation of Human herpes virus 6 genome in children with acute lymphoblastic leukemia. J Med Virol (2008) 0.82
Human herpesvirus 6B induces phosphorylation of p53 in its regulatory domain by a CK2- and p38-independent pathway. J Gen Virol (2008) 0.81
Concluding overview: looking back, looking forward. Philos Trans R Soc Lond B Biol Sci (2001) 0.81
Herpes simplex virus type 2 and cancer: a medical geography approach. Infect Genet Evol (2011) 0.81
T cell memory in the context of persistent herpes viral infections. Viruses (2012) 0.80
Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis (2012) 0.80
Direct Repeat 6 from human herpesvirus-6B encodes a nuclear protein that forms a complex with the viral DNA processivity factor p41. PLoS One (2009) 0.80
Herpes simplex virus induces unscheduled DNA synthesis in virus-infected cervical cancer cell lines. Res Virol (1993) 0.79
Human herpesvirus 6A infects human embryonic fibroblasts and induces G2/M arrest and cell death. J Med Virol (2012) 0.79
Human herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4(+) T cells. Blood (1998) 0.79
An update on Epstein-Barr virus and nasopharyngeal carcinogenesis. Head Neck Pathol (2007) 0.78
Persistent varicella as the initial manifestation of systemic lymphoma. Dermatol Online J (2008) 0.76
Evaluation of Epstein-Barr virus infection in sinonasal small round cell tumors. J Cancer Res Clin Oncol (2000) 0.76
Epstein-Barr virus-associated smooth muscle tumours after transplantation, infection with human immunodeficiency virus and congenital immunodeficiency syndromes. Pathobiology (2013) 0.76
Modulatory effects of human herpes virus-7 on cytokine synthesis and cell proliferation in human peripheral blood mononuclear cell cultures. J Leukoc Biol (1999) 0.76
Beta-cyclodextrin derivatives that inhibit anthrax lethal toxin. Bioorg Med Chem (2005) 0.99
Role of infectious agents in the carcinogenesis of brain and head and neck cancers. Infect Agent Cancer (2013) 0.97
Induction of autophagy by anthrax lethal toxin. Biochem Biophys Res Commun (2008) 0.87
Using antimicrobial adjuvant therapy in cancer treatment: a review. Infect Agent Cancer (2012) 0.86
Chick embryo extract demethylates tumor suppressor genes in osteosarcoma cells. Clin Orthop Relat Res (2014) 0.85
Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm? Infect Agent Cancer (2012) 0.80
Anthrax toxin induces hemolysis: an indirect effect through polymorphonuclear cells. J Infect Dis (2003) 0.80
Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia Virus. BMC Immunol (2010) 0.80
Childhood cancers: what is a possible role of infectious agents? Infect Agent Cancer (2013) 0.80